The objective of the current study was to delineate the pathway of complement activation that is crucial for the induction of experimental autoimmune anterior uveitis (EAAU). We studied the development of EAAU in melanin-associated antigen (MAA)-sensitized Lewis rats treated with antibody against C4 or factor B. Control animals received isotype IgG control. Antibody against C4 had no effect on EAAU, and all of the animals developed EAAU similar to those injected with control IgG. Uveitis, a vision-threatening intraocular inflammatory disease is one of the leading causes of vision loss worldwide. Anterior uveitis (AU) 2 refers to the inflammation of the anterior segment of the eye, which includes the iris and the ciliary body (CB). Idiopathic AU is the most common form of intraocular inflammation in humans (1-3). Experimental autoimmune anterior uveitis (EAAU) is an organ-specific autoimmune disease of the eye that serves as an animal model of noninfectious autoimmune idiopathic AU (4 -15). The EAAU model has been extensively used in our laboratory to understand the underlying mechanisms involved in the pathogenesis of idiopathic AU (5-15). In this experimental model, inbred Lewis rats are subcutaneously immunized in the footpad with melanin-associated antigen (MAA) isolated from the iris and the CB, and EAAU is induced in these animals by an antigen-specific CD4 ϩ T cell response to MAA (5-15). The hallmark pathologic features of EAAU include lymphocytic infiltration in the iris, the CB, and the anterior segment of the eye with no inflammation of the retina (5-15). Antigen-specific CD4 ϩ T cells can adoptively transfer disease into naïve syngenic recipients (7,8,13) and are the predominant inflammatory cells within the uvea (5-15).Previous reports from our laboratory have established a critical role of complement in EAAU (9, 10). Complement has been recognized as a key innate immune defense system that plays an important role in fighting infections and modulating various immune and inflammatory responses by bridging the innate immunity with adaptive immune responses (16 -21). The complement systems consist of more than 35 proteins circulating in blood and expressed on cell membranes. These proteins interact with one another in three distinctive activation cascades: the classical, the lectin, and the alternative, which can be triggered by different stimuli. Complement component 4 (C4) is a component of both the classical and lectin pathways, whereas factor B is the integral component of the alternative pathway (19 -21). Complement activation via these pathways is under strict control of complement regulatory proteins; disruption of the balance between complement activation and regulation can result in deleterious effects on the host and contributes to several diseases (22-36). Recently we have reported that suppression of complement activation by recombinant complement regulatory protein inhibits EAAU (15). However, the contribution of each complement activation pathway in EAAU has not yet been described. In this...